Topoisomerase II is a key enzyme in cancer therapy, but existing inhibitors suffer from toxicity and resistance issues. This project focuses on the computational design of a novel Topoisomerase II inhibitor, using molecular docking and simulations to enhance binding affinity and selectivity. By identifying more effective inhibitors, this research provides a foundation for future synthesis, in vitro validation, and potential advancements in targeted cancer treatment.